Patients with milder GLA mutations have late onset Fabry disease and circulating lyso-Gb3 around 3−18 nM, while severe GLA mutations causing classical Fabry disease and nephropathy display lyso-Gb3 levels in the 80−300 nM range in males [20,42]. This evidence concerns the gene GLA and Fabry disease.